MAWCM
VIR icon

Mine & Arao Wealth Creation & Management’s Vir Biotechnology VIR Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-115
Closed -$1.17K – 346
2024
Q1 		$1.17K Hold
115
– – ﹤0.01% 299
2023
Q4 		$1.16K Hold
115
– – ﹤0.01% 303
2023
Q3 		$1.08K Hold
115
– – ﹤0.01% 301
2023
Q2 		$2.82K Hold
115
– – ﹤0.01% 288
2023
Q1 		$2.68K Hold
115
– – ﹤0.01% 281
2022
Q4 		$2.91K Hold
115
– – ﹤0.01% 278
2022
Q3 		$2K Hold
115
– – ﹤0.01% 319
2022
Q2 		$3K Hold
115
– – ﹤0.01% 294
2022
Q1 		$3K Buy
+115
New +$3.41K ﹤0.01% 290

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's VIR Position: Q2 2024 in Review

Mine & Arao Wealth Creation & Management sold out of Vir Biotechnology (VIR) in Q2 2024, closing a stake of 115 shares — an estimated $1.17K sold.

Mine & Arao Wealth Creation & Management first reported a position in VIR in Q1 2022 and held it in 9 quarters. The position peaked at $3K in Q2 2022. 215 funds tracked by Wall St. Rank hold VIR as of Q2 2024.

  • Mine & Arao Wealth Creation & Management reported no remaining Vir Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 115 Vir Biotechnology shares in Q2 2024, an estimated $1.17K.
  • Mine & Arao Wealth Creation & Management first reported a position in Vir Biotechnology in Q1 2022 and held it in 9 quarters.
  • Mine & Arao Wealth Creation & Management's Vir Biotechnology position peaked at $3K in Q2 2022.
  • 215 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.